Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis

• Nirav N. Shah,
• Kwang Woo Ahn,
• Carlos Litovich,
• Anna Sureda,
• Mohamed A. Kharfan-Dabaja,
• Farrukh T. Awan,
• Siddhartha Ganguly,
• Usama Gergis,
• David Inwards,
• Reem Karmali,
• Alexsandr Lazaryan,
• Lazaros Lekakis,
• Pashna Munshi,
• Sunita Nathan,
• Ayman A. Saad,
• Melhem Solh,
• Amir Steinberg,
• Ravi Vij,
• William A. Wood,
• Timothy S. Fenske,
• Sonali Smith,
• Mehdi Hamadani

Affiliations

Nirav N. Shah

BMT & Cellular Therapy Program, Medical College of Wisconsin

Kwang Woo Ahn

CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin

Carlos Litovich

CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin

Anna Sureda

Hematology Department, Institut Català d’Oncologia - Hospitalet

Mohamed A. Kharfan-Dabaja

Division of HematologyOncology, Blood and Marrow Transplantation Program, Mayo Clinic

Farrukh T. Awan

Ohio Stat Medical Center, James Cancer Center

Siddhartha Ganguly

Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System

Usama Gergis

Hematolgic Malignancies & Bone Marrow Transplant, Department of Medical Oncology, New York Presbyterian Hospital/Weill Cornell Medical Center

David Inwards

Division of Hematology, Mayo Clinic

Reem Karmali

Northwestern University

Alexsandr Lazaryan

H. Lee Moffitt Cancer Center and Research Institute

Lazaros Lekakis

University of Miami

Pashna Munshi

Georgetown University Hospital

Sunita Nathan

Rush University Medical Center

Ayman A. Saad

Division of Hematology, Ohio State University

Melhem Solh

The Blood and Marrow Transplant Group of Georgia, Northside Hospital

Amir Steinberg

Division of Hematology and Oncology, Mount Sinai Hospital

Ravi Vij

Division of Hematology and Oncology, Washington University School of Medicine

William A. Wood

Division of Hematology/Oncology, Department of Medicine, University of North Carolina

Timothy S. Fenske

Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin

Sonali Smith

Section of Hematology/Oncology, The University of Chicago

Mehdi Hamadani

BMT & Cellular Therapy Program, Medical College of Wisconsin